Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Latest filing published 02 Oct 2026 for Anaptysbio, INC, €80k.
Filing timeline
BuySaleHollings Renton
Insider track record
Disclosed buys
0
Disclosed sells
14
Signal history
Hollings Renton: trading record in brief
This profile gathers the share dealings of Hollings Renton across 3 companies, led by Anaptysbio, Inc, Portola Pharmaceuticals Inc and Cepheid. The record holds 36 filings, for trades running from 26 April 2016 to 1 October 2026.
The open-market record consists of 14 sales worth €1.9M, with no purchase. Outside the open market, there are 6 share grants and 11 option exercises. 2026 to date brings no purchases and 1 sale.
On 2 October 2026 came the latest disclosure, an option exercise for €80k in Anaptysbio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Hollings Renton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations36 total
5,000 shares@ US$18.030.0061% mcap7.1% of flowCommon StockSEC:0001187333-26-000004:0
5,000 shares@ US$49.87430.017% mcap19.5% of flowCommon StockSEC:0001187333-26-000004:1
6,030 sharesCommon StockSEC:0001187333-26-000003:0
10,231 shares@ US$6.937.3% of flowCommon StockSEC:0001415889-25-021486:0
3,110 shares@ US$19.446.3% of flowCommon StockSEC:0001415889-25-021486:1
7,121 shares@ US$19.69614.5% of flowCommon StockSEC:0001415889-25-021486:2
7,250 shares@ US$23.097.8% of flowCommon StockSEC:0001415889-25-019242:1
13,675 shares@ US$23.8215.1% of flowCommon StockSEC:0001415889-25-019242:2
20,925 shares@ US$6.9314.9% of flowCommon StockSEC:0001415889-25-019242:0
3,015 shares@ US$23.977.6% of flowCommon StockSEC:0001415889-25-017819:0
6,030 shares0Common StockSEC:0001415889-25-017588:0
10,000 shares@ US$6.937.9% of flowCommon StockSEC:0001415889-24-028094:0
10,000 shares@ US$25.0028.6% of flowCommon StockSEC:0001415889-24-028094:1
10,000 shares@ US$6.937.7% of flowCommon StockSEC:0001415889-24-019676:0
7,103 shares@ US$30.503810.9% of flowCommon StockSEC:0001415889-24-019676:1
2,897 shares@ US$30.98174.5% of flowCommon StockSEC:0001415889-24-019676:2
3,900 shares0Common StockSEC:0001415889-24-017507:0
1,950 shares@ US$23.165.1% of flowCommon StockSEC:0001415889-24-017507:1
13,194 shares@ US$18.0038.6% of flowCommon StockSEC:0001209191-20-040364:0
2,826 shares@ US$18.008.3% of flowCommon StockSEC:0001209191-20-040364:1
7,281 shares@ US$18.0021.3% of flowRestricted Stock UnitsSEC:0001209191-20-040364:2
7,281 shares0Common StockSEC:0001209191-20-036781:0
5,000 shares@ US$9.004.4% of flowCommon StockSEC:0001209191-19-055045:0
5,000 shares@ US$30.0014.7% of flowCommon StockSEC:0001209191-19-055045:1
5,000 shares@ US$9.004.4% of flowCommon StockSEC:0001209191-19-045396:0
25 of 36 declarations
